JBC Connect with Cosmo for Collagen Detection

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M103139200 on August 24, 2001

J. Biol. Chem., Vol. 276, Issue 44, 41336-41342, November 2, 2001
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
276/44/41336    most recent
M103139200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dellambra, E.
Right arrow Articles by De Luca, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dellambra, E.
Right arrow Articles by De Luca, M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Gene Correction of Integrin beta 4-dependent Pyloric Atresia-Junctional Epidermolysis Bullosa Keratinocytes Establishes a Role for beta 4 Tyrosines 1422 and 1440 in Hemidesmosome Assembly*

Elena DellambraDagger , Silvia PrisleiDagger , Anna Laura SalvatiDagger , Maria Luisa MadedduDagger , Osvaldo GolisanoDagger , Emanuela SivieroDagger , Sergio BondanzaDagger , Sandra Cicuzza§, Angela Orecchia§, Filippo G. Giancotti, Giovanna Zambruno§, and Michele De LucaDagger ||

From the Dagger  Laboratory of Tissue Engineering and § Laboratory of Molecular and Cellular Biology, Istituto Dermopatico dell'Immacolata, 00167 Rome, Italy and  Cellular Biochemistry and Biophysics Program, Memorial Sloan-Kettering Cancer Center, New York, New York

Received for publication, April 9, 2001, and in revised form, August 22, 2001


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The cytoplasmic domain of beta 4 integrin contains two pairs of fibronectin-like repeats separated by a connecting segment. The connecting segment harbors a putative tyrosine activation motif in which tyrosines 1422 and 1440 are phosphorylated in response to alpha 6beta 4 binding to laminin-5. Primary beta 4-null keratinocytes, obtained from a newborn suffering from lethal junctional epidermolysis bullosa, were stably transduced with retroviruses carrying a full-length beta 4 cDNA or a beta 4 cDNA with phenylalanine substitutions at Tyr-1422 and Tyr-1440. Hemidesmosome assembly was evaluated on organotypic skin cultures. beta 4-corrected keratinocytes were indistinguishable from normal cells in terms of alpha 6beta 4 expression, the localization of hemidesmosome components, and hemidesmosome structure and density, suggesting full genetic and functional correction of beta 4-null keratinocytes. In cultures generated from beta <UP><SUB><RM><IT>4</IT></RM></SUB><SUP><RM><IT>Y1422F/Y1440F</IT></RM></SUP></UP> keratinocytes, beta 4 mutants as well as alpha 6 integrin, HD1/plectin, and BP180 were not concentrated at the dermal-epidermal junction. Furthermore, the number of hemidesmosomes was strikingly reduced as compared with beta 4-corrected keratinocytes. The rare hemidesmosomes detected in beta <UP><SUB><RM><IT>4</IT></RM></SUB><SUP><RM><IT>Y1422F/Y1440F</IT></RM></SUP></UP> cells were devoid of sub-basal dense plates and of inner cytoplasmic plaques with keratin filament insertion. Collectively, our data demonstrate that the beta 4 tyrosine activation motif is not required for the localization of alpha 6beta 4 at the keratinocyte plasma membrane but is essential for optimal assembly of bona fide hemidesmosomes.


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Human epidermis consists of a stratified squamous epithelium composed of keratinocytes organized in distinct cellular layers. Keratinocytes forming the basal layer firmly adhere to the basement membrane by means of hemidesmosomes (HDs),1 multiprotein complexes linking the epithelial intermediate filament network to the dermal anchoring fibrils (see Refs. 1 and 2 for review). HDs are formed by the clustering of several cytoplasmic and trans-membrane proteins (2). The cytoplasmic HD plaque components, which include HD1/plectin (3) and the bullous pemphigoid antigen 1 (BP230) (4), act as linkers for elements of the cytoskeleton at the cytoplasmic surface of plasma membrane. The trans-membrane constituents of HDs, which include the alpha 6beta 4 integrin (5, 6) and the bullous pemphigoid antigen 2 (BP180) (7), serve as cell receptors connecting the cell interior to extracellular matrix proteins.

In particular, the alpha 6beta 4 integrin is a receptor for the basement membrane component laminin-5, a heterotrimeric protein composed of three distinct polypeptides, alpha 3, beta 3, and gamma 2, which are encoded by three different genes known as LAMA3, LAMB3, and LAMC2, respectively (see Ref. 8 for review). Laminin-5 binds to the basal keratinocyte cell surface through the alpha 6beta 4 integrin and tightens the dermal-epidermal junction by binding also to the N-terminal NC-1 domain of type VII collagen (9). The crucial importance of the interaction between laminin-5 and its alpha 6beta 4 receptor in maintaining the integrity of the integument has been unambiguously proven by the generation of alpha 6- and beta 4-null mice (10-12) and by the identification of gene mutations in patients suffering from a devastating blistering disorder of the skin known as junctional epidermolysis bullosa (JEB). In most cases, JEB is due to mutations in LAMA3, LAMB3, and LAMC2 genes (13-15) and in ITGA6 and ITGB4 genes, which encode alpha 6 and beta 4 integrin subunits, respectively (16, 17). Mutations in ITGA6 and ITGB4 are usually associated to pyloric atresia (PA)-JEB (16, 17).

The cytoplasmic domain of alpha 6beta 4 contains two pairs of type III fibronectin (FN)-like repeats separated by a 142-amino acid connecting segment (CS). This CS is the target of multiple regulatory mechanisms, including tyrosine phosphorylation (18) and proteolytic processing (19). In particular, CS harbors tandem tyrosine phosphorylation sites (Tyr-1422 and Tyr-1440), which resemble the tyrosine activation motif (TAM) of immune receptors and are phosphorylated in response to the binding of alpha 6beta 4 to laminin-5 (18). The potential TAM resides within a 303-amino acid segment of the beta 4 cytoplasmic domain that includes the first pair of type III FN-like repeats and the CS. Mutational studies have indicated that this segment of beta 4 is sufficient to mediate the incorporation of recombinant beta 4 into the existing HD-like adhesion of 804G cells (20). We initially observed that phenylalanine substitutions at either one of the two tyrosines in the potential TAM decreased the incorporation of recombinant beta 4 in HD-like adhesions (18). Although subsequent studies have yielded a contrasting result, they have provided evidence that the integrity of the TAM is required for efficient recruitment of BP180 by recombinant beta 4 in HD-like adhesions of PA-JEB keratinocytes (21, 22). We have recently obtained evidence that the original TAM mutant used by Mainiero et al. (18) was generated starting from a version of beta 4 that differs from the canonical form A because it lacks amino acids 941-948 (QDHTIVDT) in the membrane proximal portion of the cytoplasmic domain. The origin and nature of this variant form remain to be established. We have observed that this variant form of beta 4 and a canonical form carrying phenylalanine substitutions at Tyr-1422 or Tyr-1440 are both normally incorporated in the HD-like adhesions of 804G cells (23). However, a mutant beta 4 carrying both modifications is not, as shown previously (18).

In addition to resolving the prior controversy, these results reveal a functional synergy between amino acid stretches located relatively far apart in the linear sequence of the beta 4 cytoplasmic domain and highlight the necessity to further examine the potential role of the beta 4 TAM in HD assembly. Moreover, the potential role of specific portions of the beta 4 cytoplasmic domain, and in particular of the TAM, in interaction with other HD components and in HD assembly is based solely on the results obtained using immortalized cell lines cultured on plastic. Under these conditions, both keratinocytes and 804G cells do not form HDs. Instead, HD components (such as alpha 6beta 4, BP180, and HD1/plectin) are organized in typical patches in which spots correspond to microfilament-free areas ("leopard skin" pattern, as described in Ref. 24), often referred to as HD-like adhesions (22, 25).

This said, the functional role of HD components in the proper assembly of mature HDs can in fact be studied in vitro because normal human primary keratinocytes can be cultivated in conditions that allow full epithelial differentiation (26-28) and proper assembly of mature HDs (29, 30). Keratinocytes can generate cohesive sheets of stratified epithelium that maintains virtually the same differentiation features and gene expression pattern of its in vivo counterpart so that it can be routinely transplanted in patients suffering from large skin or mucosal defects (31-33). When primary keratinocytes are seeded onto dead de-epidermized dermis in organotypic cultures (29), mature HDs are formed in vitro (30). Therefore, the availability of human beta 4-deficient primary keratinocytes (see "Results"), the possibility of stably transducing primary keratinocytes with high efficiency (34), and the possibility of subcultivating stably transduced cells in conditions in which HDs are formed (30) provide a unique opportunity to clarify the above uncertainties and to investigate the role of beta 4 and of its potential TAM in the formation of mature HDs.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Cell Culture, cDNA Constructs, and Amphotropic Producer Cell Lines-- Swiss mouse 3T3-J2 cells (a gift from Howard Green, Harvard Medical School, Boston), GP+E-86 ecotropic packaging cells, and GP+env Am12 amphotropic packaging cells were grown as described (34). Normal human epidermal keratinocytes were obtained from skin biopsies of healthy volunteers. Primary beta 4-null keratinocytes were obtained from a 1-cm2 biopsy taken from a newborn patient suffering from PA-JEB (see "Results"). Informed consent was obtained from the parents. Keratinocytes were cultivated on a feeder layer of lethally irradiated 3T3-J2 cells as described (28, 30, 33) and passaged at the stage of subconfluence.

pRC/CMV-beta <UP><SUB>4</SUB><SUP>Y1422F</SUP></UP>, pRC/CMV-beta <UP><SUB>4</SUB><SUP>Y1440F</SUP></UP>, and pRC/CMV-beta <UP><SUB>4</SUB><SUP>Y1422F/Y1440F</SUP></UP>, encoding beta 4 with phenylalanine substitutions in the TAM sequence, were constructed from partial cDNA clones covering the entire sequence of the canonical form A of beta 4 including the amino acid sequence QDHTIVDT (941) (35). A PCR fragment from pRC/CMV-beta 4 restricted with EcoRV and XhoI, containing the 3' end of beta 4 (0.443 kilobase pairs), was inserted in pBS/SK to obtain pBS/SK3'endbeta 4. A 4.968-kilobase pair fragment from pRC/CMV-beta 4 restricted with EcoRI and EcoRV was inserted in pBS/SK3'endbeta 4 to obtain full-length pBS/SK-beta 4. pLB4SN was constructed by cloning the 5.4-kilobase pair fragment from full-length pBS/SK-beta 4 into the EcoRI/XhoI sites of pLXSN retroviral vector (36) as described previously (34). The other constructs were inserted into the EcoRI/XhoI sites of pLXSN retroviral vector as described above. All constructs were sequenced before the generation of producer cell lines.

Amphotropic producer cell lines carrying each of the above constructs were generated by the transinfection protocol as described (30, 34). A control amphotropic packaging cell line was generated as above using the pLXSN retroviral vector. For each producer cell line, the viral titer was higher than 1 × 105 colony-forming units/ml.

Retroviral-mediated Gene Transfer, in Situ Hybridization, and Southern and Northern Analysis-- Infection of primary keratinocytes was performed as described previously (30, 34). Briefly, subconfluent primary beta 4-null keratinocytes were trypsinized and seeded (5 × 103 cells/cm2) onto a feeder layer (2.3 × 104 cells/cm2) composed of lethally irradiated 3T3-J2 cells and producer GP+env Am12 cells (a 1:2 mixture). After 3 days of cultivation, cells were collected and plated onto a regular 3T3-J2 feeder layer. Subconfluent cultures were used for further analysis.

Analysis of integrated proviral genomes was performed by Southern analysis as described (34). In situ hybridization was performed using the DIG Nucleic Acid Detection kit (Roche Molecular Biochemicals) following the manufacturer's instructions. Sections of cultured epidermal sheets were hybridized with a beta 4 integrin antisense riboprobe. For Northern analysis, cellular RNA was extracted with RNAfast (Sigma). 10 µg of total RNA was size-fractionated through 1% agarose-formaldehyde gels and transferred to nylon membrane (Hybond N+, Amersham Pharmacia Biotech). Blots were prehybridized at 68 °C for 2 h in 50% formamide, 5× SSC, 0.02% SDS, 2% blocking reagent, and 0.1% N-laurylsarcosine. Hybridization was performed overnight in the same conditions with the addition of 32P-labeled beta 4 integrin fragment SacII (335)/HindIII (1129) probes (2 × 106 cpm/ml). Filters were washed at high stringency in standard conditions.

Immunological Analysis-- The following antibodies were used: mouse 3E1 mAb, raised against the extracellular domain of beta 4 (Life Technologies, Inc.); goat (N20, Santa Cruz Biotechnology, Santa Cruz, CA) and rabbit polyclonal antiserum (37), both reacting against the beta 4 N terminus; rat G0H3 mAb (Serotec) and goat polyclonal T20 (Santa Cruz Biotechnology), recognizing the alpha 6 integrin; and HD121 and 1D1 mAbs (gift from Dr. K. Owaribe, Nagoya University, Nagoya, Japan) recognizing HD1/plectin and BP180, respectively.

Immunofluorescence and immunohistochemistry were performed as described (28, 30, 38). For immunoblotting, subconfluent keratinocytes were extracted on ice with lysis radioimmune precipitation buffer (50 mM Tris/HCl, pH 8.5, 150 mM NaCl, 1% deoxycholate, 1% Triton X-100, 0.1% SDS, 0.2% sodium azide). Protein content was determined by the BCA assay (Pierce). Equal amounts of total proteins were immunoprecipitated with an excess of antibody, separated by SDS-PAGE, and transferred to a nitrocellulose filter. The blot was incubated in TBST (10 mM Tris-HCl, pH 8.0, 150 mM NaCl, and 0.05% Tween 20) containing 1% bovine serum albumin, washed, and probed with specific antibodies for 1 h at room temperature. Nitrocellulose-bound antibodies were detected by chemiluminescence with ECL (Amersham Pharmacia Biotech).

Immunoprecipitations were carried out on surface-radiolabeled keratinocytes as described (39). Briefly, subconfluent keratinocytes were detached with 10 mM EDTA in phosphate-buffered saline (PBS), pH 7.4, and then washed and resuspended in PBS (2 × 107 cells/ml). Iodination was carried out for 15 min at room temperature in the presence of 1 mCi/ml of [125I]iodine (Amersham Pharmacia Biotech), 0.6 mg of lactoperoxidase, and 0.003% H2O2. After washing with 5 mM KI in PBS, cells were lysed in radioimmune precipitation buffer, pH 8.5, containing protease inhibitors (CompleteTM, Roche Molecular Biochemicals). Immunoprecipitations were carried out by overnight incubation at +4 °C of the immunoadsorbents (antibodies adsorbed onto Protein A-Sepharose, Amersham Pharmacia Biotech) with samples of cell lysates followed by extensive washing and elution by boiling in Laemmli sample buffer. Samples were then analyzed by SDS-PAGE under nonreducing conditions on 6% polyacrylamide gels followed by autoradiography. Protein-bound radioactivity in cell lysates was counted, and equivalent amounts of radioactivity were immunoprecipitated for each sample.

Organotypic Cultures and Transmission Electron Microscopy-- Keratinocytes (5 × 104 cells/cm2) were seeded onto dead de-epidermized dermis and cultivated as described (30). 7 days later, cultures were lifted at the air-liquid interface, cultured for 1 additional week, and then processed for electron microscopy. Briefly, specimens were fixed in 2% glutaraldehyde, post-fixed in 1% osmium tetroxide, dehydrated in graded alcohols, embedded in Epon resin, and sectioned on an ultramicrotome (Reichert Ultracut E, Leica, Wien, Austria). Ultrathin sections were stained with uranyl acetate and lead citrate and observed with a transmission electron microscope (CM100, Philips, Eindhoven, The Netherlands). Organotypic cultures were also sectioned on a cryostat and then analyzed by immunofluorescence as described (30).

Morphometry-- Electron micrographs of overlapping fields of the dermal-epidermal junction, taken at a magnification of × ~15,500, were printed and assembled into a montage with a final magnification of ×40,000. The prints were digitalized, using a scanner (HP ScanJet 4c), in bitmap format, and the files were analyzed using a semi-automatic image analysis system (Kontron Elektronic Imaging System KS 300). The length of dermal-epidermal junction was measured for each point, commencing at one end of the montage, and the number of HDs was counted. For each HD, the area was measured, and the percentage of HDs associated with tonofilaments was calculated. A total of 1,291 µm of cell membrane was examined, divided into: 162 µm for control keratinocytes, 116 µm for beta 4-null keratinocytes, 116 µm for beta 4-corrected keratinocytes, and 244, 441, and 212 µm for beta <UP><SUB>4</SUB><SUP>Y1422F</SUP></UP>, beta <UP><SUB>4</SUB><SUP>Y1440F</SUP></UP>, and beta <UP><SUB>4</SUB><SUP>Y1422F/Y1440F</SUP></UP> keratinocytes, respectively. A total of 443 HDs were examined, divided into: 150 for control keratinocytes, 0 for beta 4-null keratinocytes, 106 for beta 4-corrected keratinocytes, and 27, 130, and 30 for beta <UP><SUB>4</SUB><SUP>Y1422F</SUP></UP>, beta <UP><SUB>4</SUB><SUP>Y1440F</SUP></UP>, and beta <UP><SUB>4</SUB><SUP>Y1422F/Y1440F</SUP></UP> keratinocytes, respectively.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Keratinocytes were cultivated from a 1-cm2 skin biopsy taken from a newborn patient presenting with the clinical hallmarks of PA-JEB. The proband was a compound heterozygote for a 3-base pair deletion (Delta N318) in exon 8 of the maternal allele of the ITGB4 gene and an as yet unidentified paternal genetic defect. Allele-specific amplification of transcripts did not show any mRNA deriving from the paternal mutant allele, even in cycloheximide-treated cells.2 Immunohistochemical analysis showed absence of the beta 4 integrin in the skin of the proband (not shown). The keratinocytes of the proband are hereafter referred to as beta 4-null keratinocytes.

Northern blot analysis (Fig. 1) and in situ hybridization performed on cultured epidermal sheets (Fig. 2) showed similar levels of beta 4 transcripts in beta 4-null keratinocytes (Fig. 1A, lane 2, arrowhead, and Fig. 2C) as compared with normal control cells (Fig. 1A, lane 1, arrowhead, and Fig. 2A). Absence of the beta 4 polypeptide in beta 4-null cells was confirmed by immunoprecipitation followed by Western blot analysis (Fig. 1, B and C, lanes 2), immunofluorescence performed on beta 4-null colonies (not shown), and immunohistochemistry performed on cultured epidermal sheets generated by beta 4-null keratinocytes (Fig. 2D). Thus, although transcription of mutated beta 4 can occur in beta 4-null cells, the beta 4 polypeptide is either not translated or is rapidly degraded. The alpha 6 subunit (Fig. 1C, lane 2) was expressed at levels comparable with those observed in control cells (Fig. 1C, lane 1).


View larger version (25K):
[in this window]
[in a new window]
 
Fig. 1.   A, Northern analysis. 10 µg of total RNA obtained from control (1), beta 4-null (2), and beta 4-corrected (3) keratinocytes was separated by electrophoresis, transferred to nylon filters, and hybridized to a 32P-labeled beta 4-probe, to a 32P-labeled alpha 6 probe, or to a 32P-labeled GA3PDH probe. Exogenous (arrow) and endogenous (arrowhead) beta 4 transcripts are indicated. The molecular weight differences in the ectopic versus endogenous message are explained by the presence of the SV40 early promoter (SV40) and the neomycin resistance gene (NeoR) in the retroviral construct (panel D). B and C, immunoprecipitation and Western analysis. Cell extracts were prepared from control (1), beta 4-null (2), and beta 4-corrected (3) keratinocytes. Equal amounts of cell lysates were immunoprecipitated using mAbs to either beta 4 (B, IP:beta 4) or alpha 6 (C, IP:alpha 6) (3E1 and G0H3, respectively). Eluates were fractionated on 7.5% SDS-polyacrylamide gel, transferred to nitrocellulose filters, and immunostained with antisera raised against alpha 6 (T20) and beta 4 (N20), respectively. D, schematic map of the pLB4SN provirus. Solid boxes indicate the viral long terminal repeat (LTR), open boxes indicate the full-length beta 4 (beta 4) and neomycin phosphotransferase (NeoR) cDNAs, and the arrowhead-shaped box indicates the simian virus 40 early promoter.


View larger version (133K):
[in this window]
[in a new window]
 
Fig. 2.   In situ hybridization and immunohistochemistry. Cultured epidermal sheets were prepared from primary cultures of control (A and B), beta 4-null (C and D), and beta 4-corrected keratinocytes (E and F). Sections of cultured epidermal sheets were either hybridized with a beta 4 integrin antisense riboprobe (A, C, and E) or immunostained with a rabbit antiserum raised against beta 4 (B, D, and F) (19).

Gene Correction of beta 4-null Primary Keratinocytes-- Subconfluent primary cultures of beta 4-null keratinocytes were used for experiments aimed at corrective beta 4 gene transfer. Infections with replication-defective retroviruses carrying a full-length human beta 4 cDNA (Fig. 1D) were performed by co-culturing beta 4-null keratinocytes with lethally irradiated 3T3-J2 cells and producer GP+envAm12 cells (30, 38). Keratinocytes were then transferred onto a regular 3T3-J2 feeder layer both at regular density (5 × 103/cm2) and at clonal density (100-1,000 cells/dish) so that each colony was formed by a single cell and could be scored as beta <UP><SUB>4</SUB><SUP>+</SUP></UP> and beta <UP><SUB>4</SUB><SUP>−</SUP></UP>.

Southern analysis showed multiple bands resulting from numerous proviral integrations in a heterogeneous transduced cell population (not shown, see also Ref. 34). Accordingly, Northern analysis showed abundant levels of exogenous beta 4 transcripts (Fig. 1A, lane 3, arrow). Immunofluorescence (performed on coverslips seeded with keratinocytes plated at clonal density) demonstrated that clonogenic beta 4-null keratinocytes were transduced with an efficiency of virtually 100% and that the exogenous beta 4 polypeptide was localized at the cell membrane (not shown). The proper assembly of the alpha 6beta 4 heterodimer was evidenced by immunoprecipitation of cell lysates using mAbs to either beta 4 or alpha 6 (3E1 and G0H3, respectively) followed by immunoblot using antisera raised against either alpha 6 or beta 4 (T20 and N20, respectively). As shown in Fig. 1 (panels B and C), alpha 6beta 4, which was absent in beta 4-null cells (lane 2), was readily detected in beta 4-transduced keratinocytes (lanes 3) at levels comparable with those detected in normal control cells (lane 1). In situ hybridization (performed on epithelial sheets generated by beta 4-transduced keratinocytes) showed abundant levels of exogenous beta 4 transcripts both in basal and suprabasal beta 4-corrected cells (Fig. 2E). The suprabasal expression of exogenous beta 4 transcripts is expected because expression of the transgene is driven by the retroviral long terminal repeat. However, immunohistochemical analysis revealed that both in normal control cells (Fig. 2B) and in beta 4-corrected keratinocytes (Fig. 2F), the expression of the beta 4 polypeptide was restricted to the basal layer of cultured epidermal sheets. It is possible that, in the absence of its natural alpha 6 partner, exogenous beta 4 is rapidly degraded in the ER of suprabasal layers.

The localization of alpha 6beta 4 and of other HD components was then investigated in organotypic cultures, namely in conditions allowing the formation of mature HDs. In normal control cultures, alpha 6beta 4 was clearly concentrated at the basal pole of basal keratinocytes (Fig. 3A). As described previously (40), in wound healing and in organotypic cultures, a faint labeling of the lateral and apical surfaces of the basal and first suprabasal cell layer was observed (Fig. 3A). The dermal-epidermal junction was also blotted by anti-HD1/plectin (Fig. 3B) and anti-BP180 (not shown) mAbs. In beta 4-null organotypic cultures, beta 4 was virtually undetectable (Fig. 3C), whereas the alpha 6 subunit was not polarized and was diffusely distributed in the basal keratinocyte cytoplasm (not shown). Similarly, HD1/plectin (Fig. 3D) and BP180 (not shown) were not concentrated at the dermal-epidermal junction but were diffusely distributed in the cytoplasm of basal keratinocytes. Gene correction of beta 4-null keratinocytes restored the normal expression pattern of beta 4 (Fig. 3E), HD1/plectin (Fig. 3F), and BP180 (not shown). Indeed, the level of expression and the localization at the dermal-epidermal junction of the polypeptides were very similar to those observed in normal control cells (Fig. 3, A and B).


View larger version (128K):
[in this window]
[in a new window]
 
Fig. 3.   Immunofluorescence analysis of HD components in organotypic skin cultures. A and B, normal control keratinocytes. C and D, beta 4-null keratinocytes. E and F, beta 4-corrected cells. Sections of organotypic cultures were stained with an anti-beta 4 mAb (A, C, and E) and with an anti-HD1/plectin mAb (B, D, and F). Note that in control cells and in beta 4-corrected keratinocytes, beta 4 and HD1/plectin were concentrated at the basal pole of basal keratinocytes, clearly delimiting the dermal-epidermal junction. In contrast, in beta 4-null cells, beta 4 was undetectable and HD1/plectin staining was mostly pericellular.

The formation of mature HDs was investigated by transmission electron microscopy performed on ultrathin sections of organotypic skin cultures. As shown in Fig. 4, normal control keratinocytes (A) and beta 4-corrected keratinocytes (B) assembled mature HDs (stars), displaying clearly recognizable sub-basal dense plates and cytoplasmic outer and inner plaques associated with keratin intermediate filaments (arrows) distributed along their basal plasma membrane. In contrast, very few rudimentary HDs, which appeared as small, moderately electron-dense spots almost completely lacking a tripartite structure and association with keratin filaments, could be identified in beta 4-null keratinocytes (F). Thus, beta 4-corrected keratinocytes were almost indistinguishable from normal control cells in terms of alpha 6beta 4 expression, the localization of HD components, and HD structure and density, suggesting that the adhesive properties of beta 4-null keratinocytes were fully restored.


View larger version (146K):
[in this window]
[in a new window]
 
Fig. 4.   Transmission electron microscopy. Ultrastructural examination of the dermal-epidermal junction of organotypic skin cultures showed that, similarly to normal control keratinocytes (A), beta 4-corrected keratinocytes (B) assemble mature HDs displaying sub-basal dense plates (stars) and outer and inner cytoplasmic plaques associated with bundles of keratin intermediate filaments (arrows). (Anchoring filaments transversing the lamina lucida are also visible, more frequently below the HD.) beta <UP><SUB>4</SUB><SUP>Y1422F</SUP></UP> (C) and beta <UP><SUB>4</SUB><SUP>Y1440F</SUP></UP> (D) keratinocytes also display HDs (stars), which appear, however, less numerous and smaller with reduction in keratin filament association. More severe HD alterations typify beta <UP><SUB>4</SUB><SUP>Y1422F/Y1440F</SUP></UP> keratinocytes (E, at arrow), in which sub-basal dense plates appear greatly attenuated and cytoplasmic inner plaques and keratin filament insertion are almost undetectable. A marked decrease in anchoring filament density is also evident in beta 4-null and beta <UP><SUB>4</SUB><SUP>Y1422F/Y1440F</SUP></UP> keratinocytes. Bar, 200 nm.

Expression of beta 4 Mutants in Primary beta 4-null Keratinocytes-- To investigate the role of beta 4 TAM in HD formation and maturation, subconfluent primary cultures of beta 4-null keratinocytes were stably transduced with replication-defective retroviruses carrying cDNA(s) encoding: (i) beta 4 with a phenylalanine substitution at Tyr-1422 (beta <UP><SUB>4</SUB><SUP>Y1422F</SUP></UP>), (ii) beta 4 with a phenylalanine substitution at Tyr-1440 (beta <UP><SUB>4</SUB><SUP>Y1440F</SUP></UP>), and (iii) beta 4 with a combined replacement of Tyr-1422 and Tyr-1440 (beta <UP><SUB>4</SUB><SUP>Y1422F/Y1440F</SUP></UP>) (Fig. 5A). Proviral integration was demonstrated by Southern hybridization (not shown). As shown in Fig. 5B, variable levels of the different beta 4 transcripts were detected in transduced beta 4-null keratinocytes (arrow).


View larger version (32K):
[in this window]
[in a new window]
 
Fig. 5.   A, schematic map of the different beta 4 isoforms used to transduce beta 4-null keratinocytes. EC, TM, and IC indicate extracellular, transmembrane, and cytoplasmic domain, respectively. Amino acid substitutions in the CS segment are indicated. Black circles indicate the FN-like repeats. B, Northern analysis. 10 µg of total RNA obtained from control (1), beta 4-null (2), beta 4-corrected (3), beta <UP><SUB>4</SUB><SUP>Y1422F</SUP></UP> (4), beta <UP><SUB>4</SUB><SUP>Y1440F</SUP></UP> (5), and beta <UP><SUB>4</SUB><SUP>Y1422F/Y1440F</SUP></UP> (6) keratinocytes was separated by electrophoresis, transferred to nylon filters, and hybridized to a 32P-labeled beta 4-probe or to a 32P-labeled GA3PDH probe. C, immunoprecipitation and Western analysis. Cell extracts were prepared from beta 4-corrected (1), beta <UP><SUB>4</SUB><SUP>Y1422F</SUP></UP> (2), beta <UP><SUB>4</SUB><SUP>Y1440F</SUP></UP> (3), and beta <UP><SUB>4</SUB><SUP>Y1422F/Y1440F</SUP></UP> (4) keratinocytes. Equal amounts of cell lysates were immunoprecipitated using anti-beta 4 3E1 mAbs (IP:beta 4). Eluates were then fractionated on 7.5% SDS-polyacrylamide gel, transferred to nitrocellulose filters, and immunostained with antisera raised against alpha 6 and beta 4 (T20 and N20, respectively). D, immunoprecipitation. Cell extracts were prepared from surface-radioiodinated normal control cells (1), beta 4-corrected cells (2), beta <UP><SUB>4</SUB><SUP>Y1422F</SUP></UP> (3), beta <UP><SUB>4</SUB><SUP>Y1440F</SUP></UP> (4), and beta <UP><SUB>4</SUB><SUP>Y1422F/Y1440F</SUP></UP> (5) keratinocytes. Equal amounts of cell lysates were immunoprecipitated using anti-beta 4 3E1 mAbs (IP:beta 4). Eluates were then fractionated on 7.5% SDS-polyacrylamide gel and autoradiographed.

The assembly of the alpha 6beta 4 heterodimer in cells transduced with different mutants was investigated by immunoprecipitation of cell lysates using anti-beta 4 mAbs (3E1) followed by immunoblot using antisera raised against either alpha 6 or beta 4 (T20 and N20, respectively). As shown in Fig. 5C, all mutants were able to associate to the alpha 6 subunit (lanes 2-4). It is worth noting that comparable amounts of the alpha 6beta 4 heterodimer were expressed in all transduced keratinocytes (Fig. 5C).

The exposure of beta 4 on the keratinocyte plasma membrane was evaluated by immunoprecipitation of cell lysates prepared from surface-radioiodinated cells, using the anti-beta 4 3E1 mAb. As shown in Fig. 5D, equal amounts of beta 4 were exposed on the cell surface in normal control cells (lane 1), beta 4-corrected cells (lane 2), and beta 4-null cells transduced with different TAM mutants (beta <UP><SUB>4</SUB><SUP>Y1422F</SUP></UP>, beta <UP><SUB>4</SUB><SUP>Y1440F</SUP></UP>, beta <UP><SUB>4</SUB><SUP>Y1422F/Y1440F</SUP></UP>, lanes 3, 4, and 5, respectively). These data suggest that the beta 4 TAM is not essential for the localization of the alpha 6beta 4 integrin at the keratinocyte plasma membrane.

The Role of beta 4 TAM Domains in HD Formation and Maturation-- The localization of beta 4 mutants and of other HD components as well as the formation of mature HDs were investigated by immunofluorescence and transmission electron-microscopy performed on ultrathin sections of organotypic skin cultures. Immunofluorescence analysis performed on organotypic cultures prepared from beta <UP><SUB>4</SUB><SUP>Y1422F</SUP></UP> (Fig. 6, A and B), beta <UP><SUB>4</SUB><SUP>Y1440F</SUP></UP> (Fig. 6, C and D), and beta <UP><SUB>4</SUB><SUP>Y1422F/Y1440F</SUP></UP> (Fig. 6, E and F) keratinocytes showed that beta 4 mutants (Fig. 6, A, C, and E) and HD1/plectin (Fig. 6, B, D, and F) as well as alpha 6 integrin and BP180 (not shown) were not properly concentrated at the dermal-epidermal junction. Indeed, beta 4 and HD1/plectin (as well as alpha 6 and BP180) staining was clearly pericellular and of variable intensity in most areas. This is in sharp contrast with normal control cells (Fig. 3, A and B) and beta 4-corrected cells (Fig. 3, E and F) in which beta 4 (Fig. 3, A and E) and HD1/plectin (Fig. 3, B and F) as well as alpha 6 and BP180 (not shown) were concentrated at the basal pole of basal keratinocytes, clearly delimiting the dermal-epidermal junction. It is worth noting that beta 4 and HD1/plectin appeared occasionally polarized in some basal beta <UP><SUB>4</SUB><SUP>Y1422F</SUP></UP> (Fig. 6, A and B, arrow) and beta <UP><SUB>4</SUB><SUP>Y1440F</SUP></UP> (Fig. 6, C and D, arrows) cells, whereas a virtually complete impairment of beta 4 and HD1/plectin polarization was evident in beta <UP><SUB>4</SUB><SUP>Y1422F/Y1440F</SUP></UP> keratinocytes (Fig. 6, E and F).


View larger version (152K):
[in this window]
[in a new window]
 
Fig. 6.   Immunofluorescence analysis of HD components in organotypic skin cultures. A and B, beta <UP><SUB>4</SUB><SUP>Y1422F</SUP></UP> cells. C and D, beta <UP><SUB>4</SUB><SUP>Y1440F</SUP></UP>. E and F, beta <UP><SUB>4</SUB><SUP>Y1422F/Y1440F</SUP></UP> cells. Sections of organotypic cultures were stained with an anti-beta 4 mAb (A, C, and E) and with an anti-HD1/plectin mAb (B, D, and F). Note that beta 4 and HD1/plectin staining was mostly pericellular in cells transduced with beta 4 mutants. beta 4 and HD1/plectin appeared occasionally polarized in some basal beta <UP><SUB>4</SUB><SUP>Y1422F</SUP></UP> and beta <UP><SUB>4</SUB><SUP>Y1440F</SUP></UP> cells but very rarely in beta <UP><SUB>4</SUB><SUP>Y1422F/Y1440F</SUP></UP> keratinocytes (arrows in panels A-F). Thus, the cellular distribution of HD1/plectin was very similar in beta 4-null cells (Fig. 3, panel D) and in beta <UP><SUB>4</SUB><SUP>Y1422F/Y1440F</SUP></UP> keratinocytes (panel F).

As shown in Fig. 4, while beta 4-null keratinocytes (F) displayed very rare rudimentary HDs, beta 4-corrected keratinocytes (B) as well as beta <UP><SUB>4</SUB><SUP>Y1422F</SUP></UP> (C), beta <UP><SUB>4</SUB><SUP>Y1440F</SUP></UP> (D), and beta <UP><SUB>4</SUB><SUP>Y1422F/Y1440F</SUP></UP> (E) cells were able to form HDs, although with striking morphological and numerical differences. While HD structure and density in beta 4-corrected keratinocytes (B) were virtually indistinguishable from normal control cells (A), a reduction in HD number, size, tripartite structure definition, and keratin filament association was evident in beta <UP><SUB>4</SUB><SUP>Y1422F</SUP></UP> (C), beta <UP><SUB>4</SUB><SUP>Y1440F</SUP></UP> (D), and beta <UP><SUB>4</SUB><SUP>Y1422F/Y1440F</SUP></UP> (E) cells. Indeed, rare HD-like structures almost completely lacking sub-basal dense plates were detected in beta <UP><SUB>4</SUB><SUP>Y1422F/Y1440F</SUP></UP> cells (E). In most of these structures, the inner cytoplasmic plaque as well as keratin filaments that insert on cytoplasmic electron-dense plaques were almost undetectable. A marked decrease in anchoring filament density was evident in beta 4-null (F) and beta <UP><SUB>4</SUB><SUP>Y1422F/Y1440F</SUP></UP> (E) keratinocytes.

To quantify the number of HDs, the level of their maturation, and the extent of their association to intermediate filaments, a morphometric analysis of the dermal-epidermal junction was undertaken on electron micrographs of overlapping fields (41) (see "Experimental Procedures"). We have analyzed 1,291 µm of basal membrane and 443 HDs (see Table I and "Experimental Procedures"). All measurements were made by the same observer at least three times on randomly selected montages. Measurements were made on montages obtained from two different experiments, and average values are indicated.

                              
View this table:
[in this window]
[in a new window]
 
Table I
Morphometric analysis

As shown in Table I, we did not detect mature HDs in beta 4-null keratinocytes, whereas the mean values for HD counts in control cells (9.3 HDs/10 µm) and beta 4-corrected keratinocytes (9.1 HDs/10 µm) were similar. In contrast, the number of detectable HDs was strikingly reduced (up to 8-fold) in beta <UP><SUB>4</SUB><SUP>Y1422F</SUP></UP> (1.1 HDs/10 µm), beta <UP><SUB>4</SUB><SUP>Y1440F</SUP></UP> (2.9 HDs/10 µm), and beta <UP><SUB>4</SUB><SUP>Y1422F/Y1440F</SUP></UP> (1.6 HDs/10 µm) keratinocytes. Statistical analysis of the size of HDs was calculated using KS 300, a semiautomatic image analysis system, and data fell into a Gaussian distribution. The average size of HDs of control (3,897 nm2) and beta 4-corrected (3,366 nm2) keratinocytes was similar. Phenylalanine substitution at tyrosine 1422 and 1440 determined a reduction of HD size (2692 nm2 and 2181 nm2, respectively). Analysis of keratin filament association showed a marked reduction of the ability of beta <UP><SUB>4</SUB><SUP>Y1440F</SUP></UP> and beta <UP><SUB>4</SUB><SUP>Y1422F/Y1440F</SUP></UP> HDs to associate to intermediate filaments as compared with control and beta 4-corrected cells (Table I). It is worth noting, however, that even if the number of HDs formed by beta <UP><SUB>4</SUB><SUP>Y1422F</SUP></UP> keratinocytes was dramatically reduced, their ability to associate to intermediate filaments was only slightly altered. Taken together, these data indicate that beta 4 TAMs are essential for the formation of a correct number of mature HDs in basal keratinocytes.

    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The requirement for the cytoplasmic domain of beta 4 integrin in HD assembly has been clearly documented (42), and the results of this study indicate that the integrity of both tyrosine 1422 and 1440 of the beta 4 cytoplasmic TAM is demanded for the optimal assembly of bona fide HDs in human epidermis. This conclusion stands in clear contrast to prior studies indicating that TAM-mutant beta 4 localizes efficiently to endogenous HD-like adhesions of 804G cells and that it promotes assembly of HD-like adhesions in (immortalized) PA-JEB keratinocytes (22, 23), thus indicated that beta 4 TAM is dispensable for HD formation (22).

It is likely that the assembly of mature HDs has more complex molecular requirements than the formation of HD-like adhesions, which reflect the co-localization of HD components at the basal pole of cells cultivated on plastic (24). For instance, it has been suggested that the first pair of type III FN-like modules and the initial segment of the CS of beta 4 interact directly with the actin binding domain of HD1/plectin (21, 43, 44), whereas the cytoplasmic N terminus of BP180 associates with BP230 (45). In turn, HD1/plectin and BP230 associate with keratin filaments (46). Thus, both alpha 6beta 4 and BP180 can interact independently of each other with the keratinocyte intermediate filaments. Moreover, because the CS distal segment and the third type III FN-like module of beta 4 associate with the cytoplasmic domain of BP180 (22), it is likely that alpha 6beta 4 and BP180 interact as a functional unit with the two plakins and thereby with the keratin cytoskeleton.

This said, mature HDs are formed in vitro only when keratinocytes are cultivated onto de-epidermized dermis (29, 30), as in the organotypic cultures shown here. This suggests that HD-like adhesions do not recapitulate the assembly of mature HDs and might explain discrepancies between our data and data reported previously (22).

What is the mechanism by which the two tyrosine residues of the potential beta 4 TAM regulate HD assembly? The immune receptor TAMs interact in a phosphorylation-dependent manner with the tandem SH2 domains of downstream target effectors, such as the protein kinase Syk and ZAP70 (47). Based on this observation, we have previously hypothesized that phosphorylation of the potential beta 4 TAM might activate a signaling pathway necessary for proper HD formation (18). Two lines of evidence suggest that this hypothesis has to be re-evaluated. First, phosphorylation of Tyr-1422 and Tyr-1440 in response to activation of the EGF receptor correlates with disassembly (not increased assembly) of HDs (37). Second, we have recently observed that exposure to the tyrosine phosphatase inhibitor, pervanadate, promotes tyrosine phosphorylation of beta 4 and disrupts HDs. Interestingly, this effect is largely suppressed by phenylalanine substitutions at Tyr-1422 and Tyr-1440 (23). These more recent findings suggest the alternative hypothesis that the hydroxyl groups of Tyr-1422 and Tyr-1440 may be necessary for interaction with HD components such as, for instance, BP180 (22). In this model, phosphorylation of the two tyrosines may have a similar or even larger effect than their substitution to phenylalanine. Finally, there is evidence suggesting that the C-terminal tail of beta 4 folds and binds intramolecularly to a 321 amino acid segment that includes the first pair of type III FN-like repeats and part of the CS (22, 43). Since it has been speculated that this intramolecular bond may have to be disrupted to allow for association of beta 4 with HD1/plectin and/or BP180, it is possible that substitutions of the two tyrosines with phenylalanine interfere with this postulated conformational change. Future studies will distinguish among these possibilities.

    ACKNOWLEDGEMENTS

We thank Anna Bucci, Massimo Teson, and Daniela D'Agostino for technical help. We also thank the art department of Istituto Dermopatico dell'Immacolata for the artwork.

    FOOTNOTES

* This work was supported by Telethon-Italy (Grants A.106 and B-53), by EEC BIOMED 2 N° Grant BMHG4-97-2062, and by Ministero della Sanità, Italy.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

|| To whom correspondence should be addressed: Laboratory of Tissue Engineering, I. D. I, Istituto Dermopatico dell'Immacolata, Via dei Castelli Romani, 83/85, 00040 Pomezia (Roma), Italy. Tel.: 39-06-9112192; Fax: 39-06-9106765; E-mail: m.deluca@idi.it.

Published, JBC Papers in Press, August 24, 2001, DOI 10.1074/jbc.M103139200

2 Zambruno, G., unpublished data.

    ABBREVIATIONS

The abbreviations used are: HD, hemidesmosome; TAM, tyrosine activation motif; PA-JEB, pyloric atresia-junctional epidermolysis bullosa; CS, connecting segment; FN, fibronectin; mAb, monoclonal antibody.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Christiano, A. M., and Uitto, J. (1996) Exp. Dermatol. 5, 1-11
2. Borradori, L., and Sonnenberg, A. (1999) J. Invest. Dermatol. 112, 411-418
3. Wiche, G. (1998) J. Cell Sci. 111, 2477-2486
4. Stanley, J. R., Hawley-Nelson, P., Yuspa, S. H., Shevach, E. M., and Katz, S. I. (1991) Cell 24, 897-903
5. De Luca, M., Tamura, R. N., Kajiji, S., Bondanza, S., Rossino, P., Cancedda, R., Marchisio, P. C., and Quaranta, V. (1990) Proc. Natl. Acad. Sci. U. S. A. 87, 6888-6892
6. Stepp, M. A., Spurr-Michaud, S., Tisdale, A., Elwell, J., and Gibson, I. K. (1990) Proc. Natl. Acad. Sci. U. S. A. 87, 8970-8974
7. Giudice, G. J., Emery, D. J., and Diaz, L. A. (1992) J. Invest. Dermatol. 99, 243-250
8. Aumailley, M., and Krieg, T. (1996) J. Invest. Dermatol. 106, 209-214
9. Rousselle, P., Keene, D. R., Ruggiero, F., Champliaud, M. F., van der Rest, M., and Burgeson, R. E. (1997) J. Cell Biol. 138, 719-728
10. Dowling, J., Yu, Q C., and Fuchs, E. (1996) J. Cell Biol. 134, 559-572
11. Georges-Labouesse, E., Messaddeq, N., Yehia, G., Cadalbert, L., Dierich, A., and Le Meur, M. (1996) Nat. Genet. 13, 370-373
12. van der Neut, R., Krimpenfort, P., Calafat, J., Niessen, C. M., and Sonnenberg, A. (1996) Nat. Genet. 13, 366-369
13. Aberdam, D., Galliano, M. F., Vailly, J., Pulkkinen, L., Bonifas, J., Christiano, A. M., Tryggvason, K., Uitto, J., Epstein, E.-H., Ortonne, J. P., and Meneguzzi, G. (1994) Nat. Genet. 6, 299-304
14. Pulkkinen, L., Christiano, A. M., Gerecke, D., Wagman, D. W., Burgeson, R. E., Pittelkow, M. R., and Uitto, J. (1994) Genomics 24, 357-360
15. Vidal, F., Baudoin, C., Miquel, C., Galliano, M. F., Christiano, A. M., Uitto, J., Ortonne, J. P., and Meneguzzi, G. (1995) Genomics 30, 273-280
16. Vidal, F., Aberdam, D., Miquel, C., Christiano, A. M., Pulkkinen, L., Uitto, J., Ortonne, J. P., and Meneguzzi, G. (1995) Nat. Genet. 10, 229-234
17. Ruzzi, L., Gagnoux-Palacios, L., Pinola, M., Belli, S., Meneguzzi, G., D'Alessio, M., and Zambruno, G. (1997) J. Clin. Invest. 99, 2826-2831
18. Mainiero, F., Pepe, A., Wary, K. K., Spinardi, L., Mohammadi, M., Schlessinger, J., and Giancotti, F. G. (1995) EMBO J. 14, 4470-4481
19. Giancotti, F. G., Stepp, M. A., Suzuki, S., Engvall, E., and Ruoslahti, E. (1992) J. Cell Biol. 118, 951-959
20. Spinardi, L., Ren, Y. L., Sanders, R., and Giancotti, F. G. (1993) Mol. Biol. Cell 4, 871-884
21. Niessen, C.-M., Hulsman, E. H., Oomen, L. C., Kuikman, I., and Sonnenberg, A. (1997) J. Cell Sci. 110, 1705-1716
22. Schaapveld, R. Q., Borradori, L., Geerts, D., van Leusden, M. R., Kuikman, I., Nievers, M. G., Niessen, C. M., Steenbergen, R. D., Snijders, P. J., and Sonnenberg, A. (1998) J. Cell Biol. 142, 271-284